BioSpace

APRIL 24, 2024

on Wednesday launched an investigation into the exorbitant prices of Novo Nordisk’s Ozempic and Wegovy blockbusters, and has asked the Danish drugmaker to justify their price tags. Bernie Sanders (I-Vt.)

101

101

Pharmaceutical Technology

JANUARY 17, 2023

Nonetheless, patients receiving the current standard of care, Novo Nordisk’s Wegovy (injectable semaglutide), are expected to self-administer treatment on a weekly basis. Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies.

Development 130

Development Compliance Trials Marketing 130

XTalks

NOVEMBER 3, 2022

Since its US approval in June of last year, demand for Novo’s weight loss drug Wegovy has been skyrocketing, and with a recent informal endorsement from Elon Musk on Twitter , demand is only expected to further increase. Lilly is also looking to pitch Mounjaro as an obesity drug and directly take on Novo’s Wegovy.

Sales 98

Sales FDA Approval Production Insulin 98

XTalks

APRIL 29, 2022

The promising trial results could pose a threat to Danish drugmaker Novo Nordisk’s GLP-1 agonist drug Wegovy (semaglutide), which has dominated the obesity drug market since its launch in 2021. Novo introduced a higher-dose version of Saxenda called Wegovy, which won FDA approval in 2021 for chronic weight management.

Trials 98

Trials Drugs FDA Approval Clinical Trials 98

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Wegovy has been associated with a 12.4% An immediate high demand for the drug and a shortage of Wegovy resulted in supply issues. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. Wegovy has been associated with a 12.4% An immediate high demand for the drug and a shortage of Wegovy resulted in supply issues. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246